Torrent Pharmaceuticals Ltd

Torrent Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Torrent Pharmaceuticals Ltd

₹ 3,793 -0.52%
29 Dec 4:01 p.m.
torrentpharma.com BSE: 500420 NSE: TORNTPHARM
About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Key Points

Product Segments Q2 FY25
1) Branded Generics (74%): [1] The company’s branded generics business focuses on the manufacturing pharmaceutical products under its brand names catering to various therapeutic segments including cardiovascular, central nervous system, gastrointestinal, vitamin mineral nutrients, dermatology, diabetes, pain management and gynecology. Its branded generic medicines are marketed in key regions including India and Brazil. [2]

Website BSE NSE
  • Market Cap ₹ 1,28,374 Cr.
  • Current Price ₹ 3,793
  • High / Low ₹ 3,882 / 2,886
  • Stock P/E 60.1
  • Book Value ₹ 250
  • Dividend Yield 0.84 %
  • ROCE 27.8 %
  • ROE 26.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 50.5%

Cons

  • Stock is trading at 15.2 times its book value
  • The company has delivered a poor sales growth of 9.44% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty Next 50

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
1,928 1,915 1,920 2,121 2,146 2,123 2,143 2,438 2,434 2,377 2,433 2,616 2,762
1,308 1,312 1,342 1,384 1,410 1,422 1,427 1,539 1,513 1,490 1,565 1,637 1,690
Operating Profit 620 603 578 737 736 701 716 899 921 887 868 979 1,072
OPM % 32% 31% 30% 35% 34% 33% 33% 37% 38% 37% 36% 37% 39%
11 15 26 11 15 -11 76 21 -7 3 -9 -5 -40
Interest 62 91 94 90 77 69 67 64 54 48 47 45 37
Depreciation 156 185 182 183 192 191 195 189 190 191 190 187 189
Profit before tax 413 342 328 475 482 430 530 667 670 651 622 742 806
Tax % 34% 32% 33% 32% 32% 31% 23% 30% 31% 26% 24% 26% 26%
272 234 219 323 327 297 410 469 460 485 474 551 597
EPS in Rs 8.04 6.91 6.47 9.54 9.66 8.78 12.11 13.86 13.59 14.33 14.01 16.28 17.64
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
3,358 3,468 5,439 4,551 4,244 5,762 6,168 6,451 6,742 7,695 8,533 9,682 10,188
2,294 2,624 2,990 3,424 3,337 4,149 4,251 4,259 4,642 5,230 5,644 6,107 6,382
Operating Profit 1,065 843 2,450 1,127 907 1,613 1,917 2,192 2,101 2,465 2,889 3,576 3,806
OPM % 32% 24% 45% 25% 21% 28% 31% 34% 31% 32% 34% 37% 37%
32 306 292 300 332 382 237 118 204 82 91 7 -51
Interest 58 173 180 202 294 481 430 334 236 298 303 213 177
Depreciation 79 180 213 269 384 579 607 610 602 672 761 759 757
Profit before tax 958 796 2,348 955 562 935 1,117 1,366 1,466 1,577 1,917 2,610 2,821
Tax % 20% 22% 26% 11% 14% 20% 16% 17% 32% 33% 29% 28%
762 623 1,743 854 482 745 939 1,138 991 1,051 1,357 1,888 2,107
EPS in Rs 22.53 18.42 51.51 25.24 14.24 22.03 27.73 33.62 29.30 31.07 40.10 55.79 62.26
Dividend Payout % 22% 31% 34% 28% 49% 39% 58% 52% 82% 71% 70% 11%
Compounded Sales Growth
10 Years: 11%
5 Years: 9%
3 Years: 13%
TTM: 11%
Compounded Profit Growth
10 Years: 12%
5 Years: 16%
3 Years: 24%
TTM: 30%
Stock Price CAGR
10 Years: 18%
5 Years: 22%
3 Years: 35%
1 Year: 12%
Return on Equity
10 Years: 20%
5 Years: 20%
3 Years: 21%
Last Year: 26%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 85 85 85 85 85 85 85 85 85 169 169 169 169
Reserves 2,205 2,621 3,623 4,369 4,472 4,931 5,036 5,945 6,261 6,287 6,660 7,423 8,286
1,132 2,521 2,249 2,446 5,845 5,623 5,294 4,404 3,348 4,575 3,344 2,629 2,115
911 1,270 1,332 1,152 1,419 1,389 1,469 1,327 1,460 1,840 2,204 2,620 2,755
Total Liabilities 4,333 6,497 7,289 8,051 11,820 12,027 11,884 11,761 11,153 12,872 12,377 12,842 13,325
836 2,764 2,681 3,523 7,429 7,425 7,198 6,741 6,251 7,972 7,986 7,554 7,319
CWIP 508 628 984 473 447 498 536 588 568 698 226 402 485
Investments 322 434 918 936 625 486 135 314 368 361 463 523 530
2,667 2,672 2,705 3,119 3,319 3,618 4,016 4,118 3,966 3,841 3,701 4,363 4,991
Total Assets 4,333 6,497 7,289 8,051 11,820 12,027 11,884 11,761 11,153 12,872 12,377 12,842 13,325

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
310 1,065 2,403 676 929 1,232 1,580 1,573 2,140 2,265 2,893 2,574
-326 -2,099 -584 -527 -4,207 -373 269 -316 -160 -2,326 -296 -470
86 996 -1,326 -130 2,929 -928 -1,555 -1,581 -1,977 81 -2,578 -2,104
Net Cash Flow 70 -38 493 19 -349 -69 294 -325 3 20 19 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 143 124 61 82 95 86 89 87 83 82 67 82
Inventory Days 253 263 299 272 425 321 336 418 344 273 268 254
Days Payable 175 212 205 144 254 138 152 142 119 104 130 125
Cash Conversion Cycle 222 175 155 209 267 269 273 364 308 251 205 211
Working Capital Days 121 109 53 120 10 5 2 76 75 10 22 43
ROCE % 35% 22% 44% 17% 9% 13% 14% 16% 17% 18% 21% 28%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 68.31% 68.31% 68.31% 68.31%
12.09% 12.04% 12.85% 13.15% 14.08% 14.14% 14.22% 14.46% 16.17% 16.31% 16.09% 15.92%
8.77% 8.89% 8.22% 7.91% 7.11% 7.15% 7.17% 6.98% 8.25% 8.25% 8.54% 9.17%
0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10%
7.78% 7.71% 7.59% 7.59% 7.46% 7.34% 7.25% 7.21% 7.17% 7.02% 6.93% 6.47%
No. of Shareholders 65,23763,83161,57269,61269,11771,15474,76579,84885,03586,00581,85678,226

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls